Nebivolol Isomer Separation via Controlled Crystallization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for preparing and separating Nebivolol intermediates, such as RRRS and SSSR configurations, face inefficiencies and complexities, including low yield and residual isomer contamination, making them inconvenient for industrial-scale operations.
Innovation Solution
A process involving the use of alcohol and precipitation solvents, where the mixture of RRRS, SSSR, RRSR, and SSRS configurations is heated, cooled, and filtered to precipitate crystals, effectively separating RRRS and SSSR configurations with high purity and efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If fractional crystallization is used to separate Nebivolol isomers, then separation can be achieved, but the yield is quite low (6.6%)
Solution Approach 1:
The patent changes the physical parameters of the separation process by using a two-solvent system (ether solvent and alcohol solvent) with specific volume ratios, controlling temperature during cooling, and adjusting solvent composition to optimize both separation efficiency and yield of desired isomers
Solution Approach 2:
The patent utilizes phase transition through controlled cooling of the solvent mixture to precipitate crystals of desired isomers, leveraging the temperature-dependent solubility differences between isomers to achieve efficient separation with high yield
2Manufacturing precision
If multiple recrystallization treatments are performed to remove residual isomers, then purity is improved, but the process becomes complex and time-consuming
Solution Approach 1:
The patent performs preliminary action by carefully optimizing the initial crystallization conditions (solvent ratio, temperature control, cooling rate) to achieve high purity in a single step, preventing the need for multiple subsequent recrystallization treatments and simplifying the overall process
Solution Approach 2:
The patent creates a universal separation method that achieves both high purity and high yield simultaneously through a single optimized crystallization process, making the process applicable to different isomer separations without requiring multiple specialized treatment steps
3Manufacturing precision
If conventional separation methods are used, then isomers can be separated, but residual isomers remain causing inconvenience to subsequent operations
Solution Approach 1:
The patent changes the separation parameters by using a two-solvent system with specific volume ratios and controlled temperature profiles, achieving complete separation of isomers with no residual contamination, thereby ensuring ease of subsequent operations
Solution Approach 2:
The patent replaces conventional mechanical separation methods with a thermodynamically-controlled crystallization process that uses solvent-solute interactions and temperature-dependent solubility to achieve complete separation, eliminating residual isomer contamination that would complicate subsequent operations
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method simplifies the process, enhances separation efficiency, and allows for convenient scaling up to industrial levels with high purity products, overcoming previous method limitations.
Implementation Method 1
after heating, cooling down to precipitate crystals and filtrating, the product can be obtained
Implementation Method 2
the mixture of RRRS, SSSR, RRSR, and SSRS configurations is heated, cooled, and filtered to precipitate crystals
Data Source
AI summary
The invention discloses a process for isolation of a mixture of RRRS and SSSR configurations of nebivolol intermediates represented by formulae II and III respectively, which is optionally selected from one of the following two manners: (1) precipitation solvent is added to alcohol solvent comprising the mixture of RRRS, SSSR, RRSR and SSRS configurations of nebivolol intermediates represented by formula I, heating, cooling to precipitate crystals and filtrating; (2) the mixture of RRRS, SSSR, RRSR and SSRS configurations of nebivolol intermediates represented by formula I is added into the mixture solvent of alcohol solvent and precipitation solvent, heating, cooling to precipitate crystals and filtrating. In formulae I, II and III, X is H, C1-C6 alkyl or C1-C6 alkoxy, n is 1-5.


